aTYR PHARMA INC: accounts_payable
| Value | {"amount": 1431000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | aTYR PHARMA INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:49:28.461302+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/79150a5c-c3fd-4850-aa23-ca36e5ebe9c5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-014940 · Open the official SEC filing →Retrieved: 2026-08-19T12:49:28.461302+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001339970/accounts-payable/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/79150a5c-c3fd-4850-aa23-ca36e5ebe9c5
History
- no predecessors — first report